<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e>, the most common type of <z:hpo ids='HP_0003510'>dwarfism</z:hpo>, is characterized by a mutation in the fibroblast growth factor receptor 3 (FGFR3) </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Achondroplasia</z:e> is an orphan pathology with no pharmacological treatment so far </plain></SENT>
<SENT sid="2" pm="."><plain>However, the possibility of using the <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> diadenosine tetraphosphate (Ap(4)A) with therapeutic purposes in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> has been previously suggested </plain></SENT>
<SENT sid="3" pm="."><plain>The pathogenesis involves the constitutive activation of FGFR3, resulting in altered biochemical and physiological processes in chondrocytes </plain></SENT>
<SENT sid="4" pm="."><plain>Some of these altered processes can be influenced by changes in cell volume and ionic currents </plain></SENT>
<SENT sid="5" pm="."><plain>In this study, the action of mutant FGFR3 on chondrocyte size and <z:chebi fb="76" ids="17996">chloride</z:chebi> flux in achondroplastic chondrocytes was investigated as well as the effect of the Ap(4)A on these processes triggered by mutant FGFR3 </plain></SENT>
<SENT sid="6" pm="."><plain>Stimulation with the fibroblast growth factor 9 (FGF9), the preferred ligand for FGFR3, induced an enlarged achondroplastic chondrocyte size and an increase in the intracellular <z:chebi fb="76" ids="17996">chloride</z:chebi> concentration, suggesting the blockade of <z:chebi fb="76" ids="17996">chloride</z:chebi> efflux </plain></SENT>
<SENT sid="7" pm="."><plain>Treatment with the Ap(4)A reversed the morphological changes triggered by FGF9 and restored the <z:chebi fb="76" ids="17996">chloride</z:chebi> efflux </plain></SENT>
<SENT sid="8" pm="."><plain>These data provide further evidence for the therapeutic potential of this <z:chebi fb="0" ids="47885">dinucleotide</z:chebi> in <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> treatment </plain></SENT>
</text></document>